Vol 4, No 14 (July 28, 2016): Annals of Translational Medicine (Immunotherapy in cancer: the clinical impact of immune response and targeting)

Preface

Overview of advances in cancer immunotherapy
Vassiliki Kotoula, George Fountzilas
Annals of Translational Medicine  
2016;
4
(14)
:260
.
 (28 July 2016) 
PDF Full Text (3490) Open Access Get Permission

Review Article

Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou, Ourania V. Beniata, Panagiotis Vitsos, Ourania Tsitsilonis, Pinelopi Samara
Annals of Translational Medicine  
2016;
4
(14)
:261
.
 (28 July 2016) 
PDF Full Text (23639) Open Access Get Permission
Neoantigen-based cancer immunotherapy
Sara Bobisse, Periklis G. Foukas, George Coukos, Alexandre Harari
Annals of Translational Medicine  
2016;
4
(14)
:262
.
 (28 July 2016) 
PDF Full Text (11454) Open Access Get Permission
Towards tumor immunodiagnostics
Helen Kourea, Vassiliki Kotoula
Annals of Translational Medicine  
2016;
4
(14)
:263
.
 (28 July 2016) 
PDF Full Text (7764) Open Access Get Permission
DNA damage, tumor mutational load and their impact on immune responses against cancer
Michalis Liontos, Ioannis Anastasiou, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Annals of Translational Medicine  
2016;
4
(14)
:264
.
 (28 July 2016) 
PDF Full Text (6305) Open Access Get Permission
The dual role of complement in cancer and its implication in anti-tumor therapy
Ioannis Kourtzelis, Stavros Rafail
Annals of Translational Medicine  
2016;
4
(14)
:265
.
 (28 July 2016) 
PDF Full Text (9822) Open Access Get Permission
Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines
Jeanne Menez-Jamet, Catherine Gallou, Aude Rougeot, Kostas Kosmatopoulos
Annals of Translational Medicine  
2016;
4
(14)
:266
.
 (28 July 2016) 
PDF Full Text (7572) Open Access Get Permission
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics
Jessica Menis, Saskia Litière, Konstantinos Tryfonidis, Vassilis Golfinopoulos
Annals of Translational Medicine  
2016;
4
(14)
:267
.
 (28 July 2016) 
PDF Full Text (4827) Open Access Get Permission
Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting
Giannis Mountzios, Helena Linardou, Paris Kosmidis
Annals of Translational Medicine  
2016;
4
(14)
:268
.
 (28 July 2016) 
PDF Full Text (6617) Open Access Get Permission
Melanoma immunotherapy dominates the field
Panagiotis Diamantopoulos, Helen Gogas
Annals of Translational Medicine  
2016;
4
(14)
:269
.
 (28 July 2016) 
PDF Full Text (7035) Open Access Get Permission
Immunobiology and immunotherapy in genitourinary malignancies
Marinos Tsiatas, Petros Grivas
Annals of Translational Medicine  
2016;
4
(14)
:270
.
 (28 July 2016) 
PDF Full Text (6477) Open Access Get Permission
The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patients
Andreas Nearchou, George Pentheroudakis
Annals of Translational Medicine  
2016;
4
(14)
:271
.
 (28 July 2016) 
PDF Full Text (4866) Open Access Get Permission
Toxicity management of immunotherapy for patients with metastatic melanoma
Helena Linardou, Helen Gogas
Annals of Translational Medicine  
2016;
4
(14)
:272
.
 (28 July 2016) 
PDF Full Text (15507) Open Access Get Permission

Perspective

Future perspectives in cancer immunotherapy
Marinos Tsiatas, Giannis Mountzios, Giuseppe Curigliano
Annals of Translational Medicine  
2016;
4
(14)
:273
.
 (28 July 2016) 
PDF Full Text (7451) Open Access Get Permission

Disclosure:

The focused issue“Immunotherapy in cancer: the clinical impact of immune response and targeting”was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Vassiliki Kotoula and George Fountzilas served as the unpaid Guest Editors for the focused issue.